How long can you live on ARV treatment?

How long can you live on ARV treatment?

However, that number rose to 54.9 years for the most recent combination antiretroviral era. Researchers also concluded that people with HIV with higher education had a similar life expectancy to the general population. For more in-depth information and resources on HIV and AIDS, visit our dedicated hub. Think about HIV/AIDS and its lifelong antiretroviral treatment (ART). There’s a need to get patients’ lifelong commitment as soon as they start ART or there is a risk of people interrupting treatment at some point. This can result in some experiencing detectable viral load and some even becoming lost to follow-up care. Think about HIV/AIDS and its lifelong antiretroviral treatment (ART). There’s a need to get patients’ lifelong commitment as soon as they start ART or there is a risk of people interrupting treatment at some point. Patients treated later in the course of their infection, with lower CD4 cell counts (below 100 cells per μl blood), had lower life expectancy, at 32.4 years, compared with 50.4 years in patients with treated earlier with higher CD4 counts (above 200 cells per μl). Most patients initiated Multiple Tablet Regimen antiretroviral therapy (n = 255, 58%). At six months, overall viral suppression was 74.6%, being higher among patients who used Single Tablet Regimen (80.6%, p = 0.04). ART first stops active CD4 cells from making any more HIV. Viral load can drop by 90% within the first few days, and by 99% within the first few weeks. Viral load then continues to drop over the next few months. Many people become undetectable within a month and most within three months.

How long does ARV last?

Antiretroviral therapy keeps HIV from making copies of itself. When a person living with HIV begins an antiretroviral treatment regimen, their viral load drops. For almost everyone who starts taking their HIV medication daily as prescribed, viral load will drop to an undetectable level in six months or less. Treatment with HIV medicines (called antiretroviral therapy or ART) is recommended for everyone with HIV. People with HIV should start taking HIV medicines as soon as possible after HIV is diagnosed. A main goal of HIV treatment is to reduce a person’s viral load to an undetectable level. If you take HIV medicine and get and keep an undetectable viral load, you will not transmit HIV to your sex partner. Having an undetectable viral load likely reduces the risk of HIV transmission through sharing needles, syringes, or other drug injection equipment (for example, cookers), but we don’t know by how much. Missing doses of HIV medicines can reduce their usefulness and increase the possibility of developing drug resistance, which makes certain HIV drugs lose their effectiveness. If you realize you have missed a dose, go ahead and take the medication as soon as you can, then take the next dose at your usual scheduled time. Side effects from antiretroviral HIV drugs can include appetite loss, diarrhea, fatigue, and mood changes. However, not sticking to a treatment plan can cause the virus to become resistant to drugs and harder to treat. For example, nausea, fatigue, and trouble sleeping are some short-term side effects of HIV medicines. Other side effects from some HIV medicines can lead to problems that may not appear for months or years after starting a medicine. For example, high cholesterol can be a side effect of some HIV medicines.

How long can you live on ARV treatment?

However, that number rose to 54.9 years for the most recent combination antiretroviral era. Researchers also concluded that people with HIV with higher education had a similar life expectancy to the general population. For more in-depth information and resources on HIV and AIDS, visit our dedicated hub. Patients treated later in the course of their infection, with lower CD4 cell counts (below 100 cells per μl blood), had lower life expectancy, at 32.4 years, compared with 50.4 years in patients with treated earlier with higher CD4 counts (above 200 cells per μl). Most patients initiated Multiple Tablet Regimen antiretroviral therapy (n = 255, 58%). At six months, overall viral suppression was 74.6%, being higher among patients who used Single Tablet Regimen (80.6%, p = 0.04). ART first stops active CD4 cells from making any more HIV. Viral load can drop by 90% within the first few days, and by 99% within the first few weeks. Viral load then continues to drop over the next few months. Many people become undetectable within a month and most within three months. Being undetectable prevents HIV disease from progressing and allows people to live long and healthy lives. It also protects the health of their sex partners. People cannot pass HIV through sex when they have undetectable levels of HIV.

How long can you live with antiretroviral treatment?

However, that number rose to 54.9 years for the most recent combination antiretroviral era. Researchers also concluded that people with HIV with higher education had a similar life expectancy to the general population. People living with HIV who take antiretroviral medications daily as prescribed and who achieve and then maintain an undetectable viral load have effectively no risk of sexually transmitting the virus to an HIV-negative partner. Think about HIV/AIDS and its lifelong antiretroviral treatment (ART). There’s a need to get patients’ lifelong commitment as soon as they start ART or there is a risk of people interrupting treatment at some point. There are more than 30 antiretroviral medications in six drug classes; these are listed below. Each class of drug attacks HIV in a different way. Most patients initiated Multiple Tablet Regimen antiretroviral therapy (n = 255, 58%). At six months, overall viral suppression was 74.6%, being higher among patients who used Single Tablet Regimen (80.6%, p = 0.04). Although ART remains the gold standard for treatment of HIV infection, the requirement for lifelong treatment poses multiple challenges for the patient. These include stigma, an untenable pill burden, side effects, and the threat of viral resistance in the case of non-compliance.

Leave a Comment

Your email address will not be published. Required fields are marked *

three + ten =

Scroll to Top